Cargando...
NYSE: ABBV
Métricas de valuación y rentabilidad de la empresa frente a sus pares de industria. La empresa analizada aparece destacada en la primera fila.
| Empresa | Market Cap | P/E | EV/EBITDA | P/S | ROE | Margen Op. |
|---|---|---|---|---|---|---|
ABBV AbbVie Inc.Esta empresa | $376,5B | N/A | 14,05x | 5,65x | N/A | 31,56% |
LLY Eli Lilly and Company | $848,8B | N/A | 25,06x | 11,72x | 107,46% | 49,39% |
JNJ Johnson & Johnson | $557,5B | 26,39x | 16,56x | 5,53x | 26,42% | 27,41% |
MRK Merck & Company, Inc. | $295,7B | N/A | 10,87x | 4,18x | 18,94% | 38,60% |
AMGN Amgen Inc. | $178,6B | N/A | 13,18x | 4,80x | 101,32% | 33,80% |
GILD Gilead Sciences, Inc. | $163,3B | N/A | 12,50x | 5,52x | 40,66% | 37,38% |